Uwe Schlattner

17.0k total citations · 2 hit papers
153 papers, 10.1k citations indexed

About

Uwe Schlattner is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cell Biology. According to data from OpenAlex, Uwe Schlattner has authored 153 papers receiving a total of 10.1k indexed citations (citations by other indexed papers that have themselves been cited), including 121 papers in Molecular Biology, 29 papers in Cellular and Molecular Neuroscience and 29 papers in Cell Biology. Recurrent topics in Uwe Schlattner's work include Mitochondrial Function and Pathology (41 papers), Metabolism, Diabetes, and Cancer (29 papers) and Genetic Neurodegenerative Diseases (26 papers). Uwe Schlattner is often cited by papers focused on Mitochondrial Function and Pathology (41 papers), Metabolism, Diabetes, and Cancer (29 papers) and Genetic Neurodegenerative Diseases (26 papers). Uwe Schlattner collaborates with scholars based in France, Switzerland and United States. Uwe Schlattner's co-authors include Theo Wallimann, Małgorzata Tokarska-Schlattner, Dietbert Neumann, David Carling, Angela Woods, Stephen R. Johnstone, Lee G.D. Fryer, Marian Carlson, Fiona C. Leiper and Max Dolder and has published in prestigious journals such as Science, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Uwe Schlattner

147 papers receiving 9.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

LKB1 Is the Upstream Kinase in the AMP-Activated Protein Kinase Cascade

2003 1.4k citations Uwe Schlattner, Theo Wallimann et al. profile →
The creatine kinase system and pleiotropic effects of creatine

2011 560 citations Theo Wallimann, Małgorzata Tokarska-Schlattner et al. profile →

Peers

Countries citing papers authored by Uwe Schlattner

Since Specialization

Citations

This map shows the geographic impact of Uwe Schlattner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uwe Schlattner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uwe Schlattner more than expected).

Fields of papers citing papers by Uwe Schlattner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uwe Schlattner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uwe Schlattner. The network helps show where Uwe Schlattner may publish in the future.

Co-authorship network of co-authors of Uwe Schlattner

This figure shows the co-authorship network connecting the top 25 collaborators of Uwe Schlattner. A scholar is included among the top collaborators of Uwe Schlattner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uwe Schlattner. Uwe Schlattner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Preventing neuropathy and improving anticancer chemotherapy with a carbazole-based compound 2025 ·Science Advances ·(unknown), Maria Elena Pero, David Balayssac, (unknown), (unknown), (unknown), Julien Vollaire, Cécile Cottet‐Rousselle, (unknown), (unknown), Sakina Torch, (unknown), Bénédicte Elena‐Herrmann, Uwe Schlattner, (unknown), Véronique Josserand, Chantal Thibert, Patrick Dallemagne, Francesca Bartolini, Laurence Lafanéchère	0
2	Short‐term starvation activates AMPK and restores mitochondrial inorganic polyphosphate, but fails to reverse associated neuronal senescence 2024 ·Aging Cell ·Luca A. Tagliafico, (unknown), (unknown), (unknown), (unknown), Małgorzata Tokarska-Schlattner, (unknown), (unknown), Tommaso Bonfiglio, Irene Caffa, Fiammetta Monacelli, Uwe Schlattner, J. Nicholas Betley, Alessio Nencioni, María E. Solesio	4
3	Mitohormesis during advanced stages of Duchenne muscular dystrophy reveals a redox-sensitive creatine pathway that can be enhanced by the mitochondrial-targeting peptide SBT-20 2024 ·Redox Biology ·Meghan C. Hughes, Sofhia V. Ramos, (unknown), Patrick C. Turnbull, Nazari Polidovitch, (unknown), Uwe Schlattner, Thomas J. Hawke, Jeremy A. Simpson, Peter H. Backx, Christopher G. R. Perry	0
4	Knock-out of mitochondrial nucleoside diphosphate kinase NME4 reveals surprising tissue-distribution and remodeled cell signaling, suggestive of multiple functions 2023 ·Biophysical Journal ·Małgorzata Tokarska-Schlattner, (unknown), (unknown), (unknown), Laurence Kay, Uwe Schlattner	0
5	Impairments in left ventricular mitochondrial bioenergetics precede overt cardiac dysfunction and remodelling in Duchenne muscular dystrophy 2019 ·The Journal of Physiology ·Meghan C. Hughes, Sofhia V. Ramos, Patrick C. Turnbull, Brittany A. Edgett, Jason S. Huber, Nazari Polidovitch, Uwe Schlattner, Peter H. Backx, Jeremy A. Simpson, Christopher G. R. Perry	31
6	Synthetic energy sensor AMPfret deciphers adenylate-dependent AMPK activation mechanism 2019 ·Nature Communications ·(unknown), Cécile Cottet‐Rousselle, Cécile M. Bidan, Aurélie Dupont, Kapil Gupta, Imre Berger, Uwe Schlattner	69
7	Early myopathy in Duchenne muscular dystrophy is associated with elevated mitochondrial H₂O₂ emission during impaired oxidative phosphorylation 2019 ·Journal of Cachexia Sarcopenia and Muscle ·Meghan C. Hughes, Sofhia V. Ramos, Patrick C. Turnbull, Irena A. Rebalka, (unknown), Cynthia M. F. Monaco, (unknown), Brittany A. Edgett, Jason S. Huber, (unknown), (unknown), Uwe Schlattner, Jeremy A. Simpson, Thomas J. Hawke, Christopher G. R. Perry	93
8	NME4/nucleoside diphosphate kinase D in cardiolipin signaling and mitophagy 2017 ·Laboratory Investigation ·Uwe Schlattner, Małgorzata Tokarska-Schlattner, Richard M. Epand, Mathieu Boissan, Marie‐Lise Lacombe, Valerian E. Kagan	24
9	Mitochondrial NM23-H4/NDPK-D: a bifunctional nanoswitch for bioenergetics and lipid signaling 2014 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Uwe Schlattner, Małgorzata Tokarska-Schlattner, Richard M. Epand, Mathieu Boissan, Marie‐Lise Lacombe, Judith Klein‐Seetharaman, Valerian E. Kagan	12
10	Dual Function of Mitochondrial Nm23-H4 Protein in Phosphotransfer and Intermembrane Lipid Transfer 2012 ·Journal of Biological Chemistry ·Uwe Schlattner, Małgorzata Tokarska-Schlattner, (unknown), Yulia Y. Tyurina, Andrew A. Amoscato, Dariush Mohammadyani, Zhentai Huang, Jianfei Jiang, Naveena Yanamala, Amal Seffouh, Mathieu Boissan, Richard M. Epand, Judith Klein‐Seetharaman, Marie‐Lise Lacombe, Valerian E. Kagan	85
11	Development and performance of an enzyme immunoassay to detect creatine kinase isoenzyme MB activity using anti-mitochondrial creatine kinase monoclonal antibodies 2009 ·Scandinavian Journal of Clinical and Laboratory Investigation ·Tadashi Hoshino, Yasuhiro Sakai, (unknown), (unknown), (unknown), (unknown), (unknown), Uwe Schlattner, Theo Wallimann, Mitsuru Yanai, Kazunari Kumasaka	15
12	Probing the rotor subunit interface of the ATP synthase from Ilyobacter tartaricus 2008 ·FEBS Journal ·Denys Pogoryelov, Yaroslav Nikolaev, Uwe Schlattner, Konstantin Pervushin, Peter Dimroth, Thomas Meier	26
13	Reduced creatine-stimulated respiration in doxorubicin challenged mitochondria: Particular sensitivity of the heart 2007 ·Biochimica et Biophysica Acta (BBA) - Bioenergetics ·Małgorzata Tokarska-Schlattner, Max Dolder, (unknown), Oliver Speer, Theo Wallimann, Uwe Schlattner	36
14	Cardiolipin Clusters and Membrane Domain Formation Induced by Mitochondrial Proteins 2006 ·Journal of Molecular Biology ·Richard M. Epand, Małgorzata Tokarska-Schlattner, Uwe Schlattner, Theo Wallimann	83
15	Novel Lipid Transfer Property of Two Mitochondrial Proteins that Bridge the Inner and Outer Membranes 2006 ·Biophysical Journal ·Richard M. Epand, Uwe Schlattner, Theo Wallimann, Marie‐Lise Lacombe, (unknown), (unknown)	62
16	Molecular system bioenergetics: regulation of substrate supply in response to heart energy demands 2006 ·The Journal of Physiology ·Valdur Saks, R. Favier, Rita Guzun, Uwe Schlattner, Theo Wallimann	48
17	Ecdysteroid Receptors and their Applications in Agriculture and Medicine 2005 ·Vitamins and hormones ·Subba Reddy Palli, Robert E. Hormann, Uwe Schlattner, Markus Lezzi	61
18	Inhibition of the Mitochondrial Permeability Transition by Creatine Kinase Substrates 2003 ·Journal of Biological Chemistry ·Max Dolder, Bernd Walzel, Oliver Speer, Uwe Schlattner, Theo Wallimann	180
19	Creatine transporters: A reappraisal 2003 ·Molecular and Cellular Biochemistry ·Oliver Speer, Lukas J. Neukomm, Robyn M. Murphy, (unknown), Uwe Schlattner, Hugues Henry, Rodney J. Snow, Theo Wallimann	64
20	Adenylate kinase in tobacco cell cultures. I, Separation and localisation of different activities 1993 ·Archive ouverte UNIGE (University of Geneva) ·Uwe Schlattner, Edgar Wagner, Hubert Greppin, (unknown)	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact